Factor VII assays, plasma triglyceride levels, and cardiovascular disease risk.
- 1 November 1989
- journal article
- editorial
- Published by Wolters Kluwer Health in Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
- Vol. 9 (6) , 783-784
- https://doi.org/10.1161/01.atv.9.6.783
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Factor VII-Phospholipid Complex in Male Survivors of Acute Myocardial InfarctionActa Medica Scandinavica, 2009
- Effect of alteration in triglyceride levels on factor VII-phospholipid complexes in plasma.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- COFACTOR PROTEINS IN THE ASSEMBLY AND EXPRESSION OF BLOOD CLOTTING ENZYME COMPLEXESAnnual Review of Biochemistry, 1988
- Clinical Significance of HypertriglyceridemiaSeminars in Thrombosis and Hemostasis, 1988
- Epidemiologic Associations Between Hypertriglyceridemia and Coronary Heart DiseaseSeminars in Thrombosis and Hemostasis, 1988
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- A novel form of factor VII in plasma from men at risk for cardiovascular diseaseBritish Journal of Haematology, 1985
- Blood CoagulationAnnual Review of Biochemistry, 1980
- HÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDYThe Lancet, 1980
- Activation of the coagulation factor VII by tissue thromboplastin and calciumBiochemistry, 1972